Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study
Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict the risk of chronic kidney disease (CKD) progression at all stages of the disease. Using data from a diverse population…
Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association Provide Guidance on Pulmonary Hypertension Related to Interstitial Lung Disease
The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD). The PH-ILD position statement, featuring a version for…
First patient treated in the second dose group in Annexin’s RVO study
Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose have now completed treatment in the company’s clinical phase 2 study in patients with retinal vein occlusion (RVO) with the investigational drug candidate ANXV. No…
Kanazawa University research: Researchers identify the dynamic behavior of a key SARS-CoV-2 accessory protein
Researchers at Kanazawa University report in the Journal of Physical Chemistry Letters high-speed atomic force microscopy studies that shed light on the possible role of the open reading frame 6 (ORF6) protein COVID19 symptoms. While many countries across the world…
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC
Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS® (sotorasib) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC). These…
Glenmark’s innovative immune-oncology drug for advanced solid tumors and lymphomas receives FDA acceptance for Phase 1/2 clinical study
Glenmark Pharmaceuticals Ltd.’s subsidiary, Glenmark Specialty SA, has achieved a breakthrough in the fight against advanced solid tumors and lymphomas. The US Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for GRC 54276, an…
Decentralized Clinical Trial to Test Revolutionary Migraine Treatment Device
Mi-Helper, a non-invasive neuromodulation device, is set to revolutionize the treatment of migraines, a condition that affects an estimated one billion people worldwide. Developed by Mi-Helper, Inc., the small device delivers a controlled stream of conditioned air with a nebulized…
Homeopathy treatment protocols are able to reduce thyroid stimulating hormone readings in 52% patients
Homeopathic treatment protocol developed at Dr Kalyan Banerjee’s Clinic are effective in reducing thyroid stimulating hormone readings in 52% hypothyroidism patients within the first follow-up. The results were based on a study of 1200 hypothyroidism patient cases under treatment of…
Elevate Addiction Services Integrates Vivalink Platform for Real-Time Detox Monitoring in Inpatient Treatment
Vivalink, a leading provider of digital healthcare solutions, announces its biometric data platform has been successfully integrated into Elevate Addiction Services’ drug and alcohol in-patient detox treatment program. Vivalink’s Biometrics Data Platform, along with its wearable blood pressure cuff and…
At Apollo Hospitals, a 59-year-old man successfully has robotic surgery to treat his esophageal diverticulum
In a rare case of esophageal diverticulum, a 59 year old man from Yangon, Myanmar underwent a successful robot assisted minimally invasive surgery at Indraprastha Apollo Hospitals (apollohospitaldelhi).The man had been complaining of frequent episodes of vomiting/regurgitation of food after almost every…
